direkt zum Inhalt springen

direkt zum Hauptnavigationsmenü

Sie sind hier

TU Berlin

Inhalt des Dokuments

2021 [1] |2020 [2] | 2019 [3] | 2018 [4] | 2017 [5] | 2016 [6] | 2015 [7] | 2014 [8] | 2013 [9] | 2012 [10] | 2011 [11] | 2010 [12] | 2009 [13] | 2008 [14] | 2007 [15] | 2006 [16] | 2005 [17] | 2004 [18] | 2003 [19] | 2002 [20]

Vorträge 2014

Lupe [21]

Fallzahlsteigerungen im Gesundheitswesen - Impulsreferat - [22]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 02.12.2014

Lupe [23]

Auf dem Weg zu einem evidenzbasierten Gesundheitssystem [24]
Video [25]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Köln 28.11.2014

Lupe [26]
Lupe [27]

Diagnosis Related Groups in Europe: Adaptations and trends [28]
Diagnosis Related Groups en Europe: Adaptations et tendances [29]
W. Quentin
Genf 26.11.2014

Lupe [30]

Europäische Gesundheitssysteme im Vergleich – wo stehen wir? [31]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Offenbach 25.11.2014

“Living up to Improved Performance” - The role of international projects [32]
Britta Zander
Eupha 22.11.2014

Lupe [33]

Provision of health services: Trends and patterns in Europe (EU 28 + Iceland, Norway and Switzerland) [34]
W. Quentin, J. Cylus, A. Geissler, A. Maresso, S. Merkur, G. Pastorino, A. Sagan
Glasgow 21.11.2014

Lupe [35]

Gesundheitspolitik in Europa aus wissenschaftlicher Sicht [36]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 17.11.2014

Lupe [37]

Hospital payment and Diagnosis - Related Groups in Germany - Boone or Bane? [38]
Alexander Geissler, Dr.
Dubrovnik 14.11.2014

Lupe [39]

Vorstellung und Diskussion des “Health Systems in Transition” (HiT)-Profils Deutschland 2014 [40]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 14.11.2014

Lupe [41]

Forschungsauftrag zur Mengenentwicklung im Krankenhaus nach § 17b Abs. 9 KHG: Ergebnisse und Empfehlungen [42]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 27.10.2014

Lupe [43]

DRGs: Are hospitals paid for what they do – or do they do for what they are paid? And why patients should care about it [44]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Doha 21.10.2014

Lupe [45]

Medical devices: a taxonomy suitable for HTA [46]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warschau 26.09.2014

Lupe [47]

Medical devices: differences vs. other technologies, especially pharmaceuticals [48]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Warschau 26.09.2014

Lupe [49]

Qualitätsinstitute im internationalen Vergleich [50]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 22.09.2014

Lupe [51]

Inequalities in Health and Health Care [52]
Martin Siegel, Dr.
Dresden 22.09.2014

Lupe [53]

Exploring barriers and dilemmas for the adoption of cost containment strategies in the economic, institutional and political environment [54]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brüssel 17.09.2014

Lupe [55]

Sicherstellung der Versorgung – brauchen wir einen neuen ordnungspolitischen Rahmen? [56]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [57]

The German health system: basics and some comparisons with other countries [58]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 16.09.2014

Lupe [59]

Rettungsdienstliche Versorgung in Deutschland (EMSiG) [60]
Natalie Götz
Berlin 11.09.2014

Lupe [61]

From a conservative to a liberal welfare state: decomposing changes in income-related health inequalities in Germany, 1994-2011 [62]
Martin Siegel, Dr.
Dublin 16.07.2014

Lupe [63]

Towards a taxonomy of medical devices in the logic of HTA and economic evaluations rather than marketing authorization [64]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 15.07.2014

A taxonomy of medical devices in the logic of HTA [65]
Dimitra Panteli
Washington 16.06.2014

Equity considerations among HTA agencies –current practice and ways forward [66]
Dimitra Panteli
Washington 16.06.2014

The role of dissemination bias in pharmaceutical coverage decisions: an analysis of practices in European countries [67]
Dimitra Panteli
Washington 16.06.2014

The process of evidence-based decision-making for the reimbursement and pricing of pharmaceuticals in Europe: mapping approaches in 36 countries [68]
Dimitra Panteli
Washington 16.06.2014

Lupe [69]

Weiterentwicklung der Darmkrebsfrüherkennung: Themenbereich organisiertes Einladungsverfahren – Impulsreferat [70]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 23.05.2014

Lupe [71]

Deutsche Krankenhäuser im europäischen Vergleich – Ergebnisse des EuroDRG-Projektes: Wo stehen wir bezüglich Leistungsspektrum, Kosten und Qualität? [72]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 15.05.2014

Lupe [73]

Intoduction to the healthcare ecosystem and cost factors [74]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 05.05.2014

Lupe [75]

The Health Systems and Policy Monitor (HSPM) [76]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 29.04.2014

Lupe [77]

The European Observatory on Health Systems and Policies [78]
Wilm Quentin, Dr. med MSc HPPF
Brazzaville 28.04.2014

Lupe [79]

Sinn und Unsinn von Leistungsvergleichen im Krankenhaus – Erfolgskriterien, Bewertung und Referenzgrößen auf nationaler und internationaler Ebene [80]
Reinhard Busse, Prof. Dr. med. MPH FFPH
München 18.04.2014

Lupe [81]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (II) [82]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [83]

Pharmaceutical pricing, reimbursement, HTA and cost containment measures in Europe: an overview (I) [84]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [85]

Health care reform and pharmaceutical policies in Germany [86]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Beijing 11.04.2014

Lupe [87]

Addressing emerging patient needs:from free choice to integrated care [88]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Brüssel 21.03.2014

Lupe [89]

DRGs und krankheitsbezogenes Management in der stationären Versorgung aus internationaler Perspektive [90]
Reinhard Busse, Prof. Dr. med. MPH FFPH
München 18.03.2014

Lupe [91]

Hospital payment and DRGs in Germany: The G-DRG system [92]
Wilm Quentin, Dr. med MSc HPPF
Warschau 18.03.2014

Lupe [93]

Hat sich gesundheitliche Ungleichheit in Ost- und Westdeutschland seit der Wiedervereinigung unterschiedlich entwickelt? Ein Vergleich anhand der Zerlegung von Konzentrationsindizes [94]
Martin Siegel, Dr.
München 18.03.2014

Lupe [95]

The effect of continuity of ambulatory care on hospitalizations in patients with heart failure [96]
Verena Vogt
München 17.03.2014

Lupe [97]

Der Einfluss von Wettbewerb zwischen Krankenhäusern auf die Mengenentwicklung bei orthopädischen Operationen [98]
Natalie Götz
München 17.03.2014

Lupe [99]

The Latvian Health System [100]
Uldis Mittenbergs & Wilm Quentin
Brüssel 07.03.2014

Lupe [101]

Regulation and governance of providers (especially hospitals) [102]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [103]

DRGs in Europe: towards transparency, efficiency, and quality of hospital care? [104]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Jerusalem 04.03.2014

Lupe [105]

Postoperative kognitive Störungen aus Public Health-Sicht [106]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Berlin 28.02.2014

Lupe [107]

Implementing competitive UHI: benefit basket, pooling, risk-related allocation and other important considerations [108]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Dublin 23.01.2014

Lupe [109]

The financing function: Raising, pooling and allocating resources [110]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [111]

Differences in health care structure and incentives – do they worsen or reduce health inequalities? (… and a framework to examine access to health care …) [112]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

Lupe [113]

Health system reforms in times of crisis: EU countries [114]
Reinhard Busse, Prof. Dr. med. MPH FFPH
Paris 21.01.2014

------ Links: ------

Zusatzinformationen / Extras

Direktzugang

Schnellnavigation zur Seite über Nummerneingabe

Copyright TU Berlin 2008